Skip navigation
Agenda

Tracking Emerging State Price Transparency, Reporting & Disclosure Laws to Ensure Compliance

May 10, 2018
  • Philadelphia, PA

Agenda

Want more agenda details? Download the brochure.

THURSDAY, MARCH 22, 2018

7:30

Conference Registration and Continental Breakfast

8:30

Chairperson’s Opening Remarks

Jonathan Connell, JD, MBA
Senior Counsel
Bristol-Myers Squibb

8:45

Exploring the Legal and Enforcement Implications of State Drug Pricing Transparency Laws

8:45 – 9:30

I In-Depth Review of Current State Drug Pricing Reporting Law Requirements and Interpretations

William A. Sarraille
Partner
Sidley Austin LLP

9:30 – 10:00

IISpotlight on California SB-17

William A. Sarraille
Partner
Sidley Austin LLP

10:00

Networking and Refreshment Break

10:30

Policy Interactive Panel Discussion Implications of State Drug Pricing Transparency Laws on Policy

MODERATOR:

Erin E. Atkins
Associate
Arent Fox LLP

PANELISTS:

Joanne Chan
Assistant General Counsel
Pharmaceutical Research and Manufacturers of America (PhRMA)

Kristin Manzolillo
Senior Director, Global Policy
Pfizer Inc.

Kendra Martello
Senior Director, Government Affairs & Public Policy
Mallinckrodt Pharmaceuticals

11:30

Legal and Compliance Interactive Panel Discussion The Impact of State Pricing Transparency and Disclosure Legislation on Legal and Compliance Practices

MODERATOR:

Brian A. Bohnenkamp
Partner, FDA & Life Sciences Practice
King & Spalding LLP

PANELISTS:

Debbie A. Walters-Francique
Vice President, Assistant General Counsel
Pfizer Inc

Jonathan Connell, JD, MBA
Senior Counsel
Bristol-Myers Squibb

Amie Phillips Pablo
Associate Director, Compliance Government Reporting
Novo Nordisk Inc.

12:30

Networking Luncheon

1:30

Compliance Policies and Documentation Solutions for State Transparency Reporting Obligations

1:30 – 1:45

I Aligning Organizational Efforts in Compliance

Sabrina Aery
Director, 340B Compliance and State Policy Value, Access and Payment
Bristol-Myers Squibb

1:45 – 2:30

II Spotlight on New Jersey — Practical Legal and Compliance Considerations for Complying with the New Jersey Gift Ban

Brian A. Bohnenkamp
Partner, FDA & Life Sciences Practice
King & Spalding LLP

2:30

Networking and Refreshment Break

3:00

Gift Bans, Sunshine Reporting, Lobbying Registration and Disclosure Requirements — Keeping Track of the Evolving State Law Landscape

John Oroho
Executive Vice President, Chief Strategy Officer
Porzio Life Sciences, LLC

4:00

Wrap-Up Roundtable Discussion

MODERATOR:

Dr. Seth B. Whitelaw
President & CEO, Whitelaw Compliance Group
Senior Fellow & Adjunct Professor of Life Science Compliance,
Mitchell Hamline School of Law
former commercial and R&D compliance officer, GlaxoSmithKline

PANELISTS:

Jonathan Connell, JD, MBA
Senior Counsel
Bristol-Myers Squibb

John Oroho
Executive Vice President, Chief Strategy Officer
Porzio Life Sciences, LLC

5:00

Close of Conference

Networking, Wine and Cheese Reception immediately following the final session on day one

Agenda

Want more agenda details? Download the brochure.

Want more agenda details? Download the brochure.

THURSDAY, MARCH 22, 2018

7:30

Conference Registration and Continental Breakfast

8:30

Chairperson’s Opening Remarks

Jonathan Connell, JD, MBA
Senior Counsel
Bristol-Myers Squibb

8:45

Exploring the Legal and Enforcement Implications of State Drug Pricing Transparency Laws

8:45 – 9:30

I In-Depth Review of Current State Drug Pricing Reporting Law Requirements and Interpretations

William A. Sarraille
Partner
Sidley Austin LLP

9:30 – 10:00

IISpotlight on California SB-17

William A. Sarraille
Partner
Sidley Austin LLP

10:00

Networking and Refreshment Break

10:30

Policy Interactive Panel Discussion Implications of State Drug Pricing Transparency Laws on Policy

MODERATOR:

Erin E. Atkins
Associate
Arent Fox LLP

PANELISTS:

Joanne Chan
Assistant General Counsel
Pharmaceutical Research and Manufacturers of America (PhRMA)

Kristin Manzolillo
Senior Director, Global Policy
Pfizer Inc.

Kendra Martello
Senior Director, Government Affairs & Public Policy
Mallinckrodt Pharmaceuticals

11:30

Legal and Compliance Interactive Panel Discussion The Impact of State Pricing Transparency and Disclosure Legislation on Legal and Compliance Practices

MODERATOR:

Brian A. Bohnenkamp
Partner, FDA & Life Sciences Practice
King & Spalding LLP

PANELISTS:

Debbie A. Walters-Francique
Vice President, Assistant General Counsel
Pfizer Inc

Jonathan Connell, JD, MBA
Senior Counsel
Bristol-Myers Squibb

Amie Phillips Pablo
Associate Director, Compliance Government Reporting
Novo Nordisk Inc.

12:30

Networking Luncheon

1:30

Compliance Policies and Documentation Solutions for State Transparency Reporting Obligations

1:30 – 1:45

I Aligning Organizational Efforts in Compliance

Sabrina Aery
Director, 340B Compliance and State Policy Value, Access and Payment
Bristol-Myers Squibb

1:45 – 2:30

II Spotlight on New Jersey — Practical Legal and Compliance Considerations for Complying with the New Jersey Gift Ban

Brian A. Bohnenkamp
Partner, FDA & Life Sciences Practice
King & Spalding LLP

2:30

Networking and Refreshment Break

3:00

Gift Bans, Sunshine Reporting, Lobbying Registration and Disclosure Requirements — Keeping Track of the Evolving State Law Landscape

John Oroho
Executive Vice President, Chief Strategy Officer
Porzio Life Sciences, LLC

4:00

Wrap-Up Roundtable Discussion

MODERATOR:

Dr. Seth B. Whitelaw
President & CEO, Whitelaw Compliance Group
Senior Fellow & Adjunct Professor of Life Science Compliance,
Mitchell Hamline School of Law
former commercial and R&D compliance officer, GlaxoSmithKline

PANELISTS:

Jonathan Connell, JD, MBA
Senior Counsel
Bristol-Myers Squibb

John Oroho
Executive Vice President, Chief Strategy Officer
Porzio Life Sciences, LLC

5:00

Close of Conference

Networking, Wine and Cheese Reception immediately following the final session on day one